Pay in 4 interest-free payments of $6.23 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Cagrilintide Dose Escalation Studies Phase 2 trials evaluated multiple cagrilintide doses to identify the optimal balance between efficacy and tolerability: 0.3 mg weekly Minimal efficacy, excellent tolerability 0.6 mg weekly Moderate effects, good tolerability 1.2 mg weekly Strong efficacy, acceptable side effects 2.4 mg weekly Optimal efficacy-tolerability balance 4.5 mg weekly Excessive GI side effects outweighed benefits The 2.4 mg weekly dose emerged as the standard in phase 3 trials, providing substantial metabolic benefits while maintaining an acceptable side effect profile[6]
AOD-9604 peptide is frequently referenced in research literature examining growth hormone fragment signaling under controlled laboratory conditions
Keep away from direct light To preserve peptide integrity, always keep vials away from direct light
The peptide is still well within usable range
Start: 2 mg weekly for 4 weeks to assess tolerance [6]
US$ 29.27
US$ 27.47
US$ 21.16
US$ 23.16
US$ 27.38
US$ 25.34
